Effects of antibiotic use during immunotherapy in metastatic non-small cell lung cancer

by Galli, G., Poggi, M., Fucà, G., Imbimbo, M., Proto, C., Signorelli, D., Vitali, M., Zilembo, N., Ganzinelli, M., de Braud, F., Garassino, M.C., Lo Russo, G.
Published in Annals of oncology

Health-related quality of life in RAS wild-type metastatic colorectal cancer patients treated with panitumumab plus FOLFOX followed by panitumumab or panitumumab plus 5-FU/LV maint...

by Raimondi, A., Di Maio, M., Peverelli, G., Morano, F., Corallo, S., Bergamo, F., Cremolini, C., Smiroldo, V., Amatu, A., Tampellini, M., Fanchini, L., Murialdo, R., Clavarezza, M., Noventa, S., Adamo, V., Ratti, M., Petrelli, F., Antonuzzo, L., Palermo, M., de Braud, F., Di Bartolomeo, M., Pietrantonio, F.
Published in Annals of oncology

A randomized, multicenter, phase 2 trial comparing CAPTEM versus FOLFIRI as second-line treatment for MGMT-methylated, RAS-mutated metastatic colorectal cancer patients

by Pietrantonio, F., Lobefaro, R., Antista, M., Miceli, R., Raimondi, A., Lonardi, S., Rimassa, L., Saggio, S., Capone, I., Farina, G., Longarini, R., Mosconi, S., Bianchi, A. Sartore, Tomasello, G., Petrelli, F., Murgioni, S., Perrone, F., Barault, L., Milione, M., Nicolantonio, F. Di, Bartolomeo, M. Di, de Braud, F.
Published in Annals of oncology

Prospective translational study investigating circulating predictors of outcome to first-line pazopanib in patients with metastatic renal cell carcinoma (mRCC)

by Grassi, P, Verzoni, E, Ratta, R, Martinetti, A, Montone, R, Tagliabue, E, de Braud, F, Procopio, G
Published in Annals of oncology

EPSILoN score: Validation cohort of a prognostic score in advanced non-small cell lung cancer (aNSCLC) patients treated with immunotherapy

by Prelaj, A., Lo Russo, G., Signorelli, D., Ferrara, R., Imbimbo, M., Galli, G., De Toma, A., Randon, G., Brambilla, M., Trevisan, B., Ganzinelli, M., Zilembo, N., De Braud, F., Garassino, M.C., Proto, C.
Published in Annals of oncology

Anticancer innovative therapy: Highlights from the ninth annual meeting

by Volpari, T., De Santis, F., Bracken, A.P., Pupa, S.M., Buschbeck, M., Wegner, A., Di Cosimo, S., Lisanti, MP, Dotti, G., Massaia, M., Pruneri, G., Anichini, A., Fortunato, O., De Braud, F., Del Vecchio, M., Di Nicola, M.
Published in Cytokine & growth factor reviews

Hyperprogression during immuno-checkpoint inhibitors (ICIs): A clinically significant problem?

by Farè, E., Sdao, S., Damian, S., Cresta, S., Del Vecchio, M., Di Bartolomeo, M., Di Guardo, L.A., Duca, M., Indini, A., Necchi, A., Niger, M., Prisciandaro, M., Procopio, G., Raggi, D., Verzoni, E., Pruneri, G., Di Nicola, M., de Braud, F.G.M.
Published in Annals of oncology

PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-grou...

by Necchi, A., Giannatempo, P., Mariani, L., Farè, E., Raggi, D., Pennati, M., Zaffaroni, N., Crippa, F., Marchianò, A., Nicolai, N., Maffezzini, M., Togliardi, E., Daidone, M. G., Gianni, A. M., Salvioni, R., De Braud, F.
Published in Investigational new drugs

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

by JOENSUU, H, DE BRAUD, F, JALAVA, T, KAPPELER, C, AGLIETTA, M, LAURENT, D, CASALI, P. G, GRIGNAGNI, G, DE PAS, T, SPITALIERI, G, COCO, P, SPREAFICO, C, BOSELLI, S, TOFFALORIO, F, BONO, P
Published in British journal of cancer

Basal lymphopenia as a potential predictor of benefit from immunotherapy in metastatic non-small cell lung cancer

by Galli, G., Poggi, M., Fucà, G., Lo Russo, G., Proto, C., Signorelli, D., Vitali, M., Ganzinelli, M., Zilembo, N., de Braud, F., Garassino, M.C., Imbimbo, M.
Published in Annals of oncology

Impact of early steroids use on clinical outcomes of patients with advanced NSCLC treated with immune checkpoint inhibitors

by Fucà, G., Poggi, M., Galli, G., Imbimbo, M., Lo Russo, G., Signorelli, D., Vitali, M., Ganzinelli, M., Zilembo, N., de Braud, F., Garassino, M.C., Proto, C.
Published in Annals of oncology

Cancer-related fatigue and depression: a monocentric, prospective, cross-sectional study in advanced solid tumors

by Lobefaro, R., Rota, S., Porcu, L., Brunelli, C., Alfieri, S., Zito, E., Taglialatela, I., Ambrosini, M., Spagnoletti, A., Zimatore, M., Fatuzzo, G., Lavecchia, F., Borreani, C., Apolone, G., De Braud, F., Platania, M.
Published in ESMO open

Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2

by Barlesi, F., Drilon, A., De Braud, F., Cho, B.C., Ahn, M.J., Siena, S., Krebs, M.G., Lin, C.C., John, T., Tan, D.S.W., Seto, T., Dziadziuszko, R., Arkenau, H.-T., Rolfo, C., Wolf, J., Ye, C., Riehl, T., Eng, S., Doebele, R.C.
Published in Annals of oncology

Prognostic value of systemic inflammatory biomarkers in patients with mCRPC treated with Abiraterone in pre-docetaxel setting

by Ratta, R, Verzoni, E, Pantano, F, Grassi, P, De Lisi, D, Prisciandaro, M, Montone, R, Sorrentino, M, de Braud, F, Santini, D, Procopio, G
Published in Annals of oncology

Brain radiotherapy (RT) and immunotherapy (IT) for metastatic melanoma (MM): a retrospective single institution experience

by Galli, G., Cavalieri, S., Di Guardo, L., Cimminiello, C., Corti, F., Nichetti, F., Garcia, M., Tana, S., Fallai, C., de Braud, F., Platania, M., Del Vecchio, M.
Published in Annals of oncology

Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting

by De Santis, F., Del Vecchio, M., Castagnoli, L., De Braud, F., Di Cosimo, S., Franceschini, D., Fucà, G., Hiscott, J., Malmberg, K.J., McGranahan, N., Pietrantonio, F., Rivoltini, L., Sangaletti, S., Tagliabue, E., Tripodo, C., Vernieri, C., Zitvogel, L., Pupa, S.M., Di Nicola, M.
Published in Cytokine & growth factor reviews

Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors

by Serpico, D., Trama, A., Haspinger, E.R., Agustoni, F., Botta, L., Berardi, R., Palmieri, G., Zucali, P., Gallucci, R., Broggini, M., Gatta, G., Pastorino, U., Pelosi, G., de Braud, F., Garassino, M.C.
Published in Annals of oncology

Time to surgery after neoadjuvant chemotherapy for early breast cancer

by Cinausero, M, Galli, G, Basile, D, Gerratana, L, Fasola, G, De Braud, F, Sant, M, Paolini, B, Puglisi, F, Di Cosimo, S
Published in Annals of oncology

Clinical and molecular determinants of extrahepatic disease progression (ePD) in initially unresectable, liver-limited metastatic colorectal cancer (mCRC)

by Ongaro, E., Rossini, D., Pietrantonio, F., Morano, F., de Braud, F., Mazzaferro, V., Corti, F., Randon, G., Raimondi, A., Battaglia, L., Morelli, L., Urbani, L., Masi, G., Moretto, R., Antoniotti, C., Marmorino, F., Borelli, B., Zucchelli, G., Boccaccino, A., Cremolini, C., Falcone, A.
Published in Annals of oncology

Long term results of ASTER study, a single Institution phase II trial of sequential chemotherapy (CT) for operable breast cancer (BC)

by Mariani, G, Galli, G, Cavalieri, S, Valagussa, P, Bianchi, G, Capri, G, Cresta, S, Ferrari, L, Damian, S, Duca, M, de Braud, F, Moliterni, A
Published in Annals of oncology